CGEM Drug Pipeline & Catalysts | Cullinan Therapeutics, Inc. | CatalystAlert

Drug Pipeline

Drug Name	Phase	Indication	Designations
CLN-081	Phase 2	Non Small Cell Lung Cancer	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

Jan 31, 2026CLN-081

Primary completion for CLN-081 trial (NCT04036682) in Non Small Cell Lung Cancer

Regulatory Approvals

CGEM News